Join this community

CAPS community

Search this community

Here's a selection of information from patients & professionals to better understand CAPS.

Muckle Wells resources

Disease: All NOMID FCAS Muckle Wells

CAPS Frequently Asked Questions (Muckle Wells)

Here are some of the most frequently asked questions and their answers:

Muckle-Wells syndrome (MWS) is one of the cryopyrin associated periodic syndromes (CAPS) caused by mutations in the CIAS1/NLRP3 gene. These syndromes are characterized by fever, rash and joint pain.

Individuals with MWS often have episodic fever, chills, and painful joints. Sometimes these symptoms are exacerbated by cold similar to the related condition FCAS, but can also be triggered by other stimuli. In most cases, Muckle-Wells syndrome (MWS) patients develop progressive hearing loss. In some MWS cases amyloidosis develops later in life, a disease in which an abnormal accumulation of the protein amyloid occurs in a patient's tissues and organs. Accumulation of amyloid in the kidneys results in damage and often kidney failure if untreated.

CAPS Associations

These are patient organisations that have experience and expertise in CAPS diseases. They are supporters of this website. Contat them for more information on their activities.

NOMID Alliance

The NOMID Alliance is a 501 (c)(3) non-profit public charity dedicated to promoting awareness, proper diagnosis and treatment, and improved care for people with CAPS (Cryopyrin-Associated Periodic Syndromes) and other autoinflammatory syndromes.
Contact NOMID Alliance
AMWS/CINCA

French patient association provideing information and support to patients and carers living with Muckle-Wells Syndrome and CINCA/NOMID.
Contact AMWS/CINCA

CAPS Documents

Resources, documents and detailed informations on CAPS. In this section you can download brochures, ask for printed documents or find useful links.

Patient leaflet

Official leaflet of the AMWS CINCA FCAS patient association

Author/Foundation: AMWS CINCA FCAS

Year of publication: 2010

Lang: French
French Regulatory Authority information on Canakinumab (Ilaris)

A report by the French Government regulator on Canakinumab (Ilaris).

Author/Foundation: Haute Autorité de Santé

Year of publication: 2010

Lang: French
CAPS Patient Brochure

Information on CAPS from the NOMID Alliance

Author/Foundation: Karen Durrant, Dr. Raphaela Goldbach-Mansky, Dr. Hal Hoffman, Dr. Kieron Leslie, Dr. Ben Rubin

Year of publication: 2008

Lang: English
Cryopyrinopathies: update on pathogenesis and treatment

Article from the scientific review Nature in 2008 by 3 distinguished French specialists on clinical practises relating to CAPS

Author/Foundation: Bénédicte Neven, Anne-Marie Prieur and Pierre Quartier

Year of publication: 2008

Lang: English
Muckle-Wells Syndrome

Full-text content from NORD encyclopedia of Rare disease explaining different aspects of Muckle-Wells

Author/Foundation: NORD

Year of publication: 2007

Lang: English

CAPS community news

Improvement of Sensoneurinal Hearing Loss in a Patient with Muckle-Wells Syndrome Treated with Anakinra.
News, published 2 months ago
show transcript

Muckle Wells syndrome is an autoinflammatory disease in the group of cryopyrin associated periodic syndromes (CAPS). We report the case of an 8 year old girl with MWS who presented with remitting fever, urticaria, remitting coxitis, osteitis, bilateral uveitis anterior, elevated levels of C-reactive protein (CRP) and Serum amyloid A (SAA) and progressive sensoneurinal hearing loss. After starting treatment with anakinra, clinical symptoms dissolved almost completely for about two years now.
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
News, published 5 months ago
show transcript

RESULTS AVAILABLE - Status: Completed, Condition Summary: Familial Cold Autoinflammatory Syndrome (FCAS); Familial Cold Urticaria; Muckle-Wells Syndrome (MWS); Genetic Diseases, Inborn
Brain multiple sclerosis-like lesions in a patient with Muckle-Wells syndrome
News, published 5 months ago
show transcript

ARTICLE from Rheumotology (via MEDWORM). Muckle-Wells syndrome (MWS) is an autosomal dominant condition with variable penetrance characterized by recurrent fever syndromes, urticarial rash, non-exudative conjunctivitis, myalgia, arthralgia and/or arthritis, chronic headaches and/or increased intracranial pressure, chronic deafness and decreased level of energy [1]. MWS belongs to the group of cryopyrin-associated periodic fever (CAPS) including familial cold
Novartis biological drug Ilaris® approved in EU to treat children and adults with CAPS
News, published 6 months ago
show transcript

The accelerated EU decision follows approvals in the US and Switzerland, where Ilaris was granted priority review in view of the significant unmet medical need. Ilaris is the only medicine approved in the EU for CAPS patients as young as four years old
Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
News, published 6 months ago
show transcript

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced it has received marketing authorization in the European Union for rilonacept, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) with severe symptoms, including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), in adults and children aged 12 years and older
Genetics Home Reference: Muckle-Wells syndrome
News, published about 1 year ago
show transcript

(via MEDWORM) Muckle Wells on Genetics Home Reference
Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
News, published about 1 year ago
show transcript

To assess the efficacy and safety of rilonacept (Interleukin-1 [IL-1] Trap), a long-acting and potent inhibitor of IL-1, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).
New CIAS1 mutation and anakinra efficacy in overlapping of Muckle Wells
News, published over 2 years ago
show transcript

Muckle-Wells syndrome (MWS) and familial cold autoinflammatory syndrome (FCAS) are rare periodic fevers associated with CIAS1 mutations. A third entity, the chronic infantile neurological, cutaneous, articular (CINCA) syndrome was also ...